ESSA Pharma Inc. (EPIX) |
| 0.2012 -0.004 (-1.85%) 10-08 19:49 |
| Open: | 0.2 |
| High: | 0.207 |
| Low: | 0.18991 |
| Volume: | 5,945,141 |
| Market Cap: | 10(M) |
| PE Ratio: | -0.35 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.25 |
| Resistance 1: | 0.22 |
| Pivot price: | 0.20 |
| Support 1: | 0.18 |
| Support 2: | 0.15 |
| 52w High: | 6.45 |
| 52w Low: | 0.18 |
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Financials
| EPS | -0.570 |
| Book Value | 2.450 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -15.3 |
| Return on Equity (ttm) | -21.3 |
Company news
Thu, 09 Oct 2025
Alexis Bio, Inc completed the acquisition of ESSA Pharma Inc. for $80.4 million. - MarketScreener
Thu, 09 Oct 2025
XenoTherapeutics completes acquisition of ESSA Pharma By Investing.com - Investing.com Australia
Thu, 09 Oct 2025
ESSA Announces Completion of Arrangement with XenoTherapeutics - Stock Titan
Tue, 07 Oct 2025
ESSA Pharma (EPIX) Shareholders Approve Acquisition by XenoThera - GuruFocus
Mon, 06 Oct 2025
ESSA Pharma Securityholders Approve Acquisition by XenoTherapeutics - MSN
Mon, 06 Oct 2025
99.83% Vote: ESSA Securityholders Approve Acquisition by XenoTherapeutics; Completion Expected Oct 9 - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
